Updates are available Correction dated 2021-09-22
Click to view Correction: https://doi.org/10.1007/s40629-021-00179-1
-
Authors
Valbert, Frederik
Neusser, Silke
Riederer, Cordula
Wobbe-Ribinski, Stefanie
Klimek, Ludger
Sperl, Annette
Pfaar, Oliver
Werfel, Thomas
Hamelmann, Eckard
Neumann, Anja
Wasem, Jürgen
Biermann-Stallwitz, Janine
- License Information
-
More Information
Article History
Received: 21 July 2020
Accepted: 9 September 2020
First Online: 20 November 2020
Change Date: 22 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40629-021-00179-1
Conflict of interest
: O. Pfaar has received grants and/or fees from ALK-Abelló, Allergopharma, Stallergenes Greer, HAL Allergy Holding B.V./HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, Biomay, Circassia, ASIT Biotech Tools S.A, Laboratorios LETI/LETI Pharma, MEDA Pharma/MYLAN, Anergis S.A., Mobile Chamber Experts (a GA2LEN partner), Indoor Biotechnologies, Glaxo Smith Kline, Astellas Pharma Global, EUFOREA, ROXALL, NOVARTIS, SANOFI AVENTIS, Med Update Europe GmbH, streamedup! GmbH, outside the present work. T. Werfel has received grants and/or fees from Novartis, Ziarco, Sanofi-Regeneron, LEO, Galderma, Lilly, Abbvie, outside of the present work. F. Valbert, S. Neusser, C. Riederer, S. Wobbe-Ribinski, L. Klimek, A. Sperl, E. Hamelmann, A. Neumann, J. Wasem and J. Biermann-Stallwitz declare that they have no competing interests.
